$16.16
-0.52-3.12%
At close: -
$16.16
0.000.00%
After Hours: Apr 11, 4:00 PM EDT
Comments
Loading...
Tectonic Therapeutic Analyst Ratings and Price Targets | NASDAQ:TECX | Benzinga
Tectonic Therapeutic Inc has a consensus price target of $77.75 based on the ratings of 5 analysts. The high is $101 issued by Wells Fargo on March 21, 2025. The low is $65 issued by Raymond James on November 20, 2024. The 3 most-recent analyst ratings were released by Wells Fargo, Wells Fargo, and Raymond James on March 21, 2025, January 31, 2025, and November 20, 2024, respectively. With an average price target of $92.67 between Wells Fargo, Wells Fargo, and Raymond James, there's an implied 473.43% upside for Tectonic Therapeutic Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Wells Fargo
Raymond James
Leerink Partners
Piper Sandler
1calculated from analyst ratings
Analyst Ratings for Tectonic Therapeutic
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/21/2025 | Buy Now | 525% | Wells Fargo | Tiago Fauth40% | $112 → $101 | Maintains | Overweight | Get Alert |
| 01/31/2025 | Buy Now | 593.07% | Wells Fargo | Tiago Fauth40% | $79 → $112 | Maintains | Overweight | Get Alert |
| 11/20/2024 | Buy Now | 302.23% | Raymond James | Danielle Brill41% | → $65 | Initiates | → Outperform | Get Alert |
| 11/12/2024 | Buy Now | 388.86% | Wells Fargo | Tiago Fauth40% | $55 → $79 | Maintains | Overweight | Get Alert |
| 11/11/2024 | Buy Now | 326.98% | Leerink Partners | David Risinger72% | $49 → $69 | Maintains | Outperform | Get Alert |
| 08/22/2024 | Buy Now | 240.35% | Wells Fargo | Tiago Fauth40% | → $55 | Initiates | → Overweight | Get Alert |
| 07/24/2024 | Buy Now | 203.22% | Leerink Partners | David Risinger72% | → $49 | Initiates | → Outperform | Get Alert |
| 06/26/2024 | Buy Now | 370.3% | Piper Sandler | Yasmeen Rahimi52% | → $76 | Initiates | → Overweight | Get Alert |
| 06/24/2024 | Buy Now | — | TD Cowen | Tyler Van Buren44% | — | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Tectonic Therapeutic (TECX) stock?
The latest price target for Tectonic Therapeutic (NASDAQ:TECX) was reported by Wells Fargo on March 21, 2025. The analyst firm set a price target for $101.00 expecting TECX to rise to within 12 months (a possible 525.00% upside). 9 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Tectonic Therapeutic (TECX)?
The latest analyst rating for Tectonic Therapeutic (NASDAQ:TECX) was provided by Wells Fargo, and Tectonic Therapeutic maintained their overweight rating.
When was the last upgrade for Tectonic Therapeutic (TECX)?
There is no last upgrade for Tectonic Therapeutic
When was the last downgrade for Tectonic Therapeutic (TECX)?
There is no last downgrade for Tectonic Therapeutic.
When is the next analyst rating going to be posted or updated for Tectonic Therapeutic (TECX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Tectonic Therapeutic, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Tectonic Therapeutic was filed on March 21, 2025 so you should expect the next rating to be made available sometime around March 21, 2026.
Is the Analyst Rating Tectonic Therapeutic (TECX) correct?
While ratings are subjective and will change, the latest Tectonic Therapeutic (TECX) rating was a maintained with a price target of $112.00 to $101.00. The current price Tectonic Therapeutic (TECX) is trading at is $16.16, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.